Lexeo Therapeutics (LXEO) Net Cash Flow (2022 - 2026)
Lexeo Therapeutics (LXEO) reported Net Cash Flow of $8.8 million for Q1 2026, up 243.62% on a YoY basis from $2.6 million in Q1 2025, and down 60.15% sequentially from $22.0 million in Q4 2025.
Lexeo Therapeutics (LXEO) Net Cash Flow (2022 - 2026) Analysis & Trends
Lexeo Therapeutics (LXEO) has 5 years of Net Cash Flow data on file, last reported at $8.8 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow rose 243.62% year-over-year to $8.8 million; the trailing twelve-month figure through Mar 2026 stood at $42.9 million (up 125.79% YoY), and the FY2025 full-year result was $28.0 million, up 132.37% from the prior year.
- Net Cash Flow eased to $8.8 million in Q1 2026, from $22.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $86.0 million in Q4 2023 to a low of -$122.0 million in Q4 2024.
- A 5-year average of -$1.6 million and a median of -$8.1 million in 2023 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow jumped 611.58% in 2023 and tumbled 241.84% in 2024, its largest moves.
- Tracing LXEO's Net Cash Flow over 5 years: stood at -$16.8 million in 2022, then jumped by 611.58% to $86.0 million in 2023, then plunged by 241.84% to -$122.0 million in 2024, then jumped by 118.04% to $22.0 million in 2025, then slumped by 60.15% to $8.8 million in 2026.
- Business Quant data shows LXEO's Net Cash Flow at $8.8 million in Q1 2026, $22.0 million in Q4 2025, and $5.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Lexeo Therapeutics | 382.38 Mn | 382.38 Mn | - | 8.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.77 Mn |
| Mar 31, 2026 | 8.77 Mn |
| Dec 31, 2025 | 22.00 Mn |
| Dec 31, 2025 | 22.00 Mn |
| Sep 30, 2025 | 5.52 Mn |
| Sep 30, 2025 | 5.52 Mn |
| Jun 30, 2025 | 6.57 Mn |
| Jun 30, 2025 | 6.57 Mn |
| Mar 31, 2025 | -6.11 Mn |
| Mar 31, 2025 | -6.11 Mn |
| Dec 31, 2024 | -122.01 Mn |
| Dec 31, 2024 | -122.01 Mn |
| Sep 30, 2024 | -17.96 Mn |
| Sep 30, 2024 | -17.96 Mn |
| Jun 30, 2024 | -20.08 Mn |
| Jun 30, 2024 | -20.08 Mn |
| Mar 31, 2024 | 73.59 Mn |
| Mar 31, 2024 | 73.59 Mn |
| Dec 31, 2023 | 86.02 Mn |
| Dec 31, 2023 | 86.02 Mn |